Sacroiliac Joint Fusion Market To Reach $2.49 Billion By 2030

Sacroiliac Joint Fusion Market Growth & Trends

The global sacroiliac joint fusion market size is expected to reach USD 2.49 billion by 2030, according to a new report by Grand View Research, Inc.It is expected to expand at a CAGR of 19.8% from 2024 to 2030. Key market players are investing substantially in Research & Development (R&D) activities to create innovative and effective devices. This increase in R&D activities is expected to drive market growth over the coming years. In addition, the market is expected to grow further due to the increasing prevalence of bone disorders and ongoing technological advancements.

Increasing prevalence of lower back, buttock, groin, and lower extremity pain drives SI joint fusion market growth. These chronic and debilitating forms of pain have become alarmingly common, affecting a substantial portion of the global population. This trend poses significant challenges to healthcare systems and fuels demand for innovative solutions to alleviate suffering and restore mobility. Chronic pain in the lower back, buttock, groin, and lower extremity represents a significant portion of SI joint disorder cases, comprising 10% to 26% of such cases, as the Centers for Medicare & Medicaid Services reported in December 2021. The prevalence of symptoms associated with SI joint disorders highlights their substantial healthcare challenge.

In addition, a factor propelling market growth is the increasing use of innovative materials and technologies to develop improved and safer SI joint fusion systems. For instance, in October 2022, Aurora Spine, a company specializing in regenerative technologies focusing on minimally invasive approaches, announced that it had received 510(k) clearance from the U.S. FDA for its patented SiLO TFX MIS. The SI joint fixation system is a minimally invasive solution intended for SI joint fusion in cases involving SI joint disruptions and degenerative sacroiliitis. The SiLO TFX system comprises an ilium screw, sacrum screw, associated instrumentation, and transfixing cone designed to achieve fixation and stability for bony fusion between the sacrum and ilium. Thus, such technological advancements are expected to boost market growth.

North America dominated the market with the largest revenue share in 2023. North America is the leading market for upper limb prosthetics across the globe. The dominance can be attributed to advanced healthcare infrastructure, the presence of key companies, and growing reimbursement coverage. Key market players are involved in implementing strategic initiatives, such as conducting clinical tests of their products, regional expansion, patent applications, product launches, and partnerships & collaborations to increase their market share.

 Request a free sample copy or view report summary: Sacroiliac Joint Fusion Market Report

Sacroiliac Joint Fusion Market Report Highlights

• By indication, the degenerative sacroiliitis segment accounted for the largest revenue share of 38.6% in 2023. Growing awareness about the condition and improving diagnostic capabilities for sacroiliac joint disorders are among the major factors that drive the growth of the segment.

• By treatment type, surgery segment dominated the market in terms of revenue share in 2023. Its dominance is attributed to the growing preference for minimally invasive surgeries, driven by their advantages, including smaller incisions, decreased pain & scarring, and quicker recovery periods.

• By end user, the hospitals segment dominated the market in 2023. Hospitals offer specialized, extended care for patients, and their treatments are frequently eligible for reimbursement, further fostering their adoption.

• North America dominated the market with the largest revenue share in 2023 owing to well-established healthcare infrastructure and increasing R&D investments by companies.

• Asia Pacific region is expected to grow at the fastest rate during the forecast period, owing to the presence of a large patient pool, developing healthcare facilities, and investments by key companies in this region.

Sacroiliac Joint Fusion Market Segmentation

Grand View Research has segmented the global sacroiliac joint fusion market based on indication, treatment type, end-user, and region:

Sacroiliac Joint Fusion Indication Outlook (Revenue, USD Million, 2018 - 2030)

• Degenerative Sacroiliitis

• Sacral Disruption

• Trauma

Sacroiliac Joint Fusion Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)

• Surgery

  • By Surgery Type

    • MIS

    • MIS

  • By Approach

    • Dorsal

    • Anterior

  • By Product

    • Implants

    • Accessories

• Injections

  • Diagnosis

  • Treatment

• RF Ablation

Sacroiliac Joint Fusion End-user Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Ambulatory Surgical Centers

• Others (Specialty Centers, Research & Academic Institutes)

Sacroiliac Joint Fusion Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Sacroiliac Joint Fusion Market

• SI-BONE, Inc.

• PainTEQ

• CornerLoc

• SIGNUS Medizintechnik GmbH

• Globus Medical

• Orthofix Medical, Inc.

• Life Spine, Inc.

• Camber Spine Technologies, LLC

• CoreLink Surgical

• Xtant Medical

• Surgalign Spine Technologies, Inc.

• Medtronic